These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28119480)
1. Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling. Mesev EV; Miller DS; Cannon RE Mol Pharmacol; 2017 Apr; 91(4):373-382. PubMed ID: 28119480 [TBL] [Abstract][Full Text] [Related]
2. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier. Soldner ELB; Hartz AMS; Akanuma SI; Pekcec A; Doods H; Kryscio RJ; Hosoya KI; Bauer B FASEB J; 2019 Dec; 33(12):13966-13981. PubMed ID: 31638830 [TBL] [Abstract][Full Text] [Related]
4. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. Cartwright TA; Campos CR; Cannon RE; Miller DS J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528 [TBL] [Abstract][Full Text] [Related]
5. PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression. More VR; Campos CR; Evans RA; Oliver KD; Chan GN; Miller DS; Cannon RE J Cereb Blood Flow Metab; 2017 Apr; 37(4):1199-1212. PubMed ID: 27193034 [TBL] [Abstract][Full Text] [Related]
6. Effects of ceramide, ceramidase inhibition and expression of ceramide kinase on cytosolic phospholipase A2alpha; additional role of ceramide-1-phosphate in phosphorylation and Ca2+ signaling. Shimizu M; Tada E; Makiyama T; Yasufuku K; Moriyama Y; Fujino H; Nakamura H; Murayama T Cell Signal; 2009 Mar; 21(3):440-7. PubMed ID: 19101626 [TBL] [Abstract][Full Text] [Related]
7. Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers. Wang X; Campos CR; Peart JC; Smith LK; Boni JL; Cannon RE; Miller DS J Neurosci; 2014 Jun; 34(25):8585-93. PubMed ID: 24948812 [TBL] [Abstract][Full Text] [Related]
8. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Bauer B; Hartz AM; Pekcec A; Toellner K; Miller DS; Potschka H Mol Pharmacol; 2008 May; 73(5):1444-53. PubMed ID: 18094072 [TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic Acid Signaling Axis Mediates Ceramide 1-Phosphate-Induced Proliferation of C2C12 Myoblasts. Bernacchioni C; Cencetti F; Ouro A; Bruno M; Gomez-Muñoz A; Donati C; Bruni P Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300303 [TBL] [Abstract][Full Text] [Related]
10. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation. Yousif S; Chaves C; Potin S; Margaill I; Scherrmann JM; Declèves X J Neurochem; 2012 Nov; 123(4):491-503. PubMed ID: 22845665 [TBL] [Abstract][Full Text] [Related]
11. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Wang X; Sykes DB; Miller DS Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. Hoffmann K; Löscher W Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. Hartz AM; Madole EK; Miller DS; Bauer B J Pharmacol Exp Ther; 2010 Aug; 334(2):467-76. PubMed ID: 20460386 [TBL] [Abstract][Full Text] [Related]
14. Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Zibell G; Unkrüer B; Pekcec A; Hartz AM; Bauer B; Miller DS; Potschka H Neuropharmacology; 2009 Apr; 56(5):849-55. PubMed ID: 19371577 [TBL] [Abstract][Full Text] [Related]
15. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly. Miller DS Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266 [TBL] [Abstract][Full Text] [Related]
16. Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor. Hawkins BT; Sykes DB; Miller DS J Neurosci; 2010 Jan; 30(4):1417-25. PubMed ID: 20107068 [TBL] [Abstract][Full Text] [Related]
17. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy. Kikuchi DS; Campos ACP; Qu H; Forrester SJ; Pagano RL; Lassègue B; Sadikot RT; Griendling KK; Hernandes MS J Neuroinflammation; 2019 Nov; 16(1):241. PubMed ID: 31779628 [TBL] [Abstract][Full Text] [Related]
18. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology. Miller DS Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212 [TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate. Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030 [TBL] [Abstract][Full Text] [Related]
20. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Hartz AM; Bauer B; Fricker G; Miller DS Mol Pharmacol; 2006 Feb; 69(2):462-70. PubMed ID: 16278373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]